FDA inspection
Lupin Limited: FDA inspection ending May 19, 2017
FDA inspection 1012540 · Official Action Indicated (OAI) · Pithampur
Key facts
| Inspection ID | 1012540 |
|---|---|
| Firm | Lupin Limited |
| FEI number | 3007549629 |
| Address | Unit-2, Plot No. M-2 And M-2-A, Sez, Phase Ii, Misc. Zone, Apparel Park, Dist. Dhar |
| City | Pithampur |
| Country | India |
| Fiscal year | 2017 |
| Inspection end date | May 19, 2017 |
| Classification | Official Action Indicated (OAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
| Warning letter | 535014 |
At a glance
- None Citations
- 1–9 Posted citations
- Yes Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data